Video Experimental Relacionado
Updated: Feb 28, 2026

Validation of Nanobody and Antibody Based In Vivo Tumor Xenograft NIRF-imaging Experiments in Mice Using Ex Vivo Flow Cytometry and Microscopy
Published on: April 6, 2015
Plataforma de nanopartículas decorada con nanobodies derivados de bacterias para restaurar la inmunidad de las
Jinzhou Cai1, Xiangming Han1, Yu Zhang1
1Department of Pathology, The First Affiliated Hospital, State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection & School for Radiological and Interdisciplinary Sciences (RAD-X), Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Cancer Institute, Suzhou Medical College, Soochow University, Suzhou, Jiangsu 215123, China.
Abstract:
T cell exhaustion within the tumor immune microenvironment (TIME) impairs the efficacy of radioimmunotherapy. Here, we demonstrate that X-ray radiotherapy induces arginine metabolic dysregulation and PD-L1 upregulation in the tumor microenvironment (TME), suppressing T cell metabolism and driving the expansion of PD-1+TIM-3+ exhausted T cells, thereby promoting immunosuppression. To address this, we design a biomimetic hybrid immunomodulator (arg/Bnb-L) by engineering BL-21 bacterial membranes to display PD-L1 nanobodies and fusing them with l-arginine-loaded liposomes. This nanoplatform simultaneously blocks PD-1/PD-L1 immune checkpoint signaling and restores T cell metabolic activity while promoting dendritic cell maturation. In murine tumor models, arg/Bnb-L combined with radiotherapy significantly enhances CD8+ T cell infiltration, reduces exhausted T cell populations, maintains cytotoxic T lymphocyte function, and inhibits tumor progression and metastasis. Our study elucidates a dual mechanism underlying radiotherapy-induced immunosuppression and offers a promising strategy to enhance radioimmunotherapy outcomes through targeted metabolic and immunologic reprogramming.

